A prospective analysis of the effect of blue-dye volume on sentinel lymph node mapping success and incidence of allergic reaction in patients with breast cancer

Annals of Surgical Oncology

Volumn 11, Issue 5, 2004, Pages 535-541

  King, Tari A ^a,b   Fey, Jane V ^a   Van Zee, Kimberly J ^a   Heerdt, Alexandra S ^a   Gemignani, Mary L ^a   Port, Elisa Rush ^a   Sclafani, Lisa ^a   Sacchini, Virgilio ^a   Petrek, Jeanne A ^a   Cody III, Hiram S ^a   Borgen, Patrick I ^a   Montgomery, Leslie L ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b MRI 1026 ^*  (United States)

Author keywords

Allergic reactions; Breast cancer; Isosulfan blue dye; Sentinel lymph node

Indexed keywords

CORTICOSTEROID; DIPHENHYDRAMINE; EPHEDRINE; HYPERTENSIVE FACTOR; ISOSULFAN BLUE; RADIOISOTOPE; DIAGNOSTIC AGENT; FUCHSINE; ISO SULFAN BLUE; ISO-SULFAN BLUE;

ADULT; AGED; ALLERGIC REACTION; ARTICLE; BREAST CANCER; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; PRURITUS; RASH; RISK ASSESSMENT; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY; SIDE EFFECT; STATISTICAL SIGNIFICANCE; URTICARIA; BREAST TUMOR; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; DRUG HYPERSENSITIVITY; FEMALE; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PROSPECTIVE STUDY; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; DRUG HYPERSENSITIVITY; FEMALE; HUMANS; HYPOTENSION; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; ROSANILINE DYES; SENTINEL LYMPH NODE BIOPSY;

EID: 3242813923     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1245/ASO.2004.10.014     Document Type: Article

References (24)

1. Hill ADK, Tran KN, Akhurst T, et al. Lessons learned from 500 cases of lymphatic mapping for breast cancer. Ann Surg 1999;229:528-35.
2. Cody HS, Fey J, Akhurst T, et al. Complementarity of blue dye and isotope in sentinel node localization for breast cancer: univariate and multivariate analysis of 966 procedures. Ann Surg Oncol 2001;8:13-9.
3. McMasters KM, Tuttle TM, Carlson DJ, et al. Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used. J Clin Oncol 2000;18:2560-6.
4. Cody HS, Borgen PI. State-of-the-art approaches to sentinel node biopsy for breast cancer: study design, patient selection, technique, and quality control at Memorial Sloan-Kettering Cancer Center. Surg Oncol 1999;8:85-91.
5. Kuerer HM, Hunt KK, Singletary E, Ames FC. Blue hives during lymphatic mapping for breast cancer (letter). J Clin Oncol 2001;19:2573-4.
6. Lymphazurin 1% (package insert). Bedford, OH: Ben Venue Laboratories Inc, 1997.
7. Kuerer HM, Wayne JD, Ross MI. Anaphylaxis during breast cancer lymphatic mapping (letter). Surgery 2001;129:119-20.
8. Lyew MA, Gamblin TC, Ayoub M. Systemic anaphylaxis associated with intramammary isosulfan blue injection used for sentinel node detection under general anesthesia. Anesthesiology 2000;93:1145-6.
9. Leong SP, Donegan E, Heffernon W, et al. Adverse reactions to isosulfan blue during selective sentinel lymph node dissection in melanoma. Ann Surg Oncol 2000;7:361-6.
10. Efron P, Knudsen E, Hirshorn S, Copeland EM. Anaphylactic reaction to isosulfan blue used for sentinel node biopsy: case report and literature review. Breast J 2002;8:396-9.
11. Albo D, Wayne JD, Hunt KK, et al. Anaphylactic reactions to isosulfan blue dye during sentinel lymph node biopsy for breast cancer. Am J Surg 2001;182:393-8.
12. Montgomery LL, Thorne AC, Van Zee KJ, et al. Isosulfan blue dye reactions during sentinel lymph node mapping for breast cancer. Anesth Analg 2002;95:385-8.
13. Linehan DC, Hill ADK, Tran KN, et al. Sentinel lymph node localization in breast cancer: unfiltered isotope is superior to filtered. J Am Coll Surg 1999;188:377-81.
14. McCarter MD, Yeung H, Yeh S, et al. Localization of the sentinel node in breast cancer: identical results with same-day and day-before isotope injection. Ann Surg Oncol 2001;8:682-6.
15. Boolbol SK, Fey JV, Borgen PI, et al. Intradermal isotope injection: a highly accurate method of lymphatic mapping in breast carcinoma. Ann Surg Oncol 2001;8:20-4.
16. McMasters KM, Wong SL, Martin RCG, et al. Dermal injection of radioactive colloid is superior to peritumoral injection for breast cancer sentinel lymph node biopsy: results of a multiinstitutional study. Ann Surg 2001;233:676-87.
17. Bares R, Muller B, Fass J, Buell U, Schumpelick V. The radiation dose to surgical personnel during intraoperative radioimmunoscintimetry. Eur J Nucl Med 1992;19:110-2.
18. Miner TJ, Shriver CD, Flicek PR, et al. Guidelines for the safe use of radioactive materials during localization and resection of the sentinel lymph node. Ann Surg Oncol 1999;6:75-82.
19. Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat 1979;6:65-70.
20. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220:391-401.
21. Derossis AM, Fey J, Yeung H, et al. A trend analysis of the relative value of blue dye and isotope localization in 2,000 consecutive cases of sentinel node biopsy for breast cancer. J Am Coll Surg 2001;193:473-8.
22. Vokach-Brodsky L, Jeffrey SS, Lemmens HJM, Brock-Utne JG. Isosulfan blue affects pulse oximetry. Anesthesiology 2000;93:1002-3.
23. Kelloher JF. Pulse oximetry. J Clin Monit 1989;5:37-40.
24. Wayne JD, Albo D, Hunt K, et al. Anaphylactic reaction to isosulfan blue dye (IBD) during sentinel lymph node biopsy (SLNB) is more common in breast cancer than in melanoma (abstract 150). Proc ASCO 2001;20:38a.